Who founded Qu Biologics?

Qu Biologics was founded by Harold David Gunn.

Who are Qu Biologics's investors?

Qu Biologics's investors include Curitas Ventures, Harmonix Fund.

How much funding has Qu Biologics raised?

Qu Biologics has disclosed $48.8K raised across 1 round.

Where is Qu Biologics headquartered?

Qu Biologics is headquartered in Burnaby.

Qu Biologics

Burnaby · 2 known investors

Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.

Biotech Healthtech

Founders & leadership

Harold David GunnFounder

Simon SutcliffeChief Medical Officer

Alun ReesNamed on SEC filing

Robert E. PelzerNamed on SEC filing

Michael LeschukNamed on SEC filing

Gillian VandermeirschNamed on SEC filing

Jim PankovichNamed on SEC filing

Julia LevyNamed on SEC filing

Hal GunnCEO

Investors · 2

Curitas VenturesStockholm

Harmonix FundLa Quinta

Reported raises · per SEC filings

Form D private placements

$48.8K disclosed across 1 round · 2018

▶$48.8KraisedJun 2018 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Simon SutcliffeExecutive Officer, Director
Alun ReesExecutive Officer
Robert E. PelzerDirector
Michael LeschukDirector
Harold David GunnExecutive Officer, Director
Gillian VandermeirschExecutive Officer
Jim PankovichExecutive Officer
Julia LevyDirector

Offering amount: $77.6K
Amount sold: $48.8K
First sale: May 2018
Incorporated: Corporation, British Columbia, Canada
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

IQVIA26 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.

Q32 Bio19 shared keywordsQ32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.

Q Bio, Inc.12 shared keywordsQ.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.

Companies competing with Qu Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Qu Biologics do?: Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.
Who founded Qu Biologics?: Qu Biologics was founded by Harold David Gunn.
Who are Qu Biologics's investors?: Qu Biologics's investors include Curitas Ventures, Harmonix Fund.
How much funding has Qu Biologics raised?: Qu Biologics has disclosed $48.8K raised across 1 round.
Where is Qu Biologics headquartered?: Qu Biologics is headquartered in Burnaby.